Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase
暂无分享,去创建一个
P. Browett | A. Schwarer | I. Gathmann | Z. Rudzki | D. Ma | J. Seymour | T. Hughes | S. Durrant | D. Joske | S. Branford | A. Grigg | K. Bradstock | C. Arthur | K. Bradstock | K. Lynch | K. Taylor | A. Harper | D. Ma | T. Hughes